High-Level Aminoglycoside Resistance in the Beta-Hemolytic Group G Streptococcus Isolate BM2721

AUTOR(ES)

Galimand, Marc

FONTE

American Society for Microbiology

RESUMO

The beta-hemolytic group G Streptococcus clinical isolate BM2721 was resistant to high levels of aminoglycosides by synthesis of AAC(6′)-APH(2"), APH(3′)-III, and ANT(6) modifying enzymes. The corresponding genes were found to be adjacent as the result of a recombination event between Tn4001 and Tn5405, two transposons originating in staphylococci.

Documentos Relacionados

• High-level aminoglycoside resistance in group A, B, G, D (Streptococcus bovis), and viridans streptococci.
• High-level chromosomal gentamicin resistance in Streptococcus agalactiae (group B).
• Group B beta-hemolytic streptococci causing pharyngitis.
• Artificial Elimination of Drug Resistance from Group A Beta-Hemolytic Streptococci
• Susceptibility of group A beta-hemolytic Streptococcus isolates to penicillin and erythromycin.